Trial Profile
A study evaluating Adalimumab versus Infliximab in treating post-operative recurrence of Crohn's disease: a national cohort study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2017
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Infliximab
- Indications Crohn's disease
- Focus Therapeutic Use
- 06 Nov 2017 New trial record